Segment Information

12 Months Ended

Dec. 31, 2012

Segment Reporting, Measurement Disclosures [Abstract]

Segment Data

SEGMENT INFORMATION

The Company operates and reports its results in five separate business segments consisting of the Test & Measurement, Environmental, Life Sciences & Diagnostics, Dental and Industrial Technologies segments. In addition, the historical results of the hand tools related business (which was contributed to the Apex joint venture) and the Company’s equity in earnings of the Apex joint venture is shown separately in the Company’s segment disclosures. Operating profit represents total revenues less operating expenses, excluding other expense, interest and income taxes. The identifiable assets by segment are those used in each segment’s operations. Inter-segment amounts are not significant and are eliminated to arrive at consolidated totals.

Detailed segment data for the years ended December 31, 2012, 2011 and 2010 is presented in the following table ($ in millions):

	2012			2011			2010
Total sales:
Test & Measurement	$	3,381.0		$	3,390.9		$	2,832.9
Environmental	3,063.5			2,939.6			2,738.0
Life Sciences & Diagnostics	6,485.1			4,627.4			2,298.3
Dental	2,022.9			2,011.2			1,824.6
Industrial Technologies	3,307.9			3,121.4			2,540.6
Businesses contributed to Apex joint venture attributable to periods prior to contribution	—			—			315.6
	$	18,260.4		$	16,090.5		$	12,550.0
Operating profit:
Test & Measurement	$	701.2		$	751.2		$	572.9
Environmental	652.5			622.7			564.3
Life Sciences & Diagnostics	861.1			402.3			227.9
Dental	293.1			236.1			203.3
Industrial Technologies	685.6			655.0			513.3
Businesses contributed to Apex joint venture:
Attributable to periods prior to contribution	—			—			41.5
Equity method earnings subsequent to joint venture formation	69.9			66.8			22.8
Other	(98.3		)	(116.9		)	(96.4		)
	$	3,165.1		$	2,617.2		$	2,049.6
Identifiable assets (including assets held for sale):
Test & Measurement	$	5,505.8		$	5,280.6		$	5,322.9
Environmental	3,146.6			2,784.8			2,634.9
Life Sciences & Diagnostics	13,305.2			12,888.4			4,071.7
Dental	4,079.9			4,047.5			4,120.2
Industrial Technologies	4,235.6			3,394.9			2,876.8
Other	2,667.9			1,553.3			3,190.6
	$	32,941.0		$	29,949.5		$	22,217.1

Depreciation and amortization:
Test & Measurement	$	132.3	$	126.6	$	107.7
Environmental	48.9		45.9		45.9
Life Sciences & Diagnostics	478.2		297.2		90.7
Dental	92.4		94.0		81.7
Industrial Technologies	80.8		65.8		51.5
Businesses contributed to Apex joint venture attributable to periods prior to contribution	—		—		6.2
Other	7.2		5.5		4.6
	$	839.8	$	635.0	$	388.3

	2012		2011		2010
Capital expenditures, gross
Test & Measurement	$	37.5	$	37.7	$	35.6
Environmental	29.5		29.1		25.4
Life Sciences & Diagnostics	296.8		167.0		49.6
Dental	30.2		35.4		31.8
Industrial Technologies	49.0		51.3		35.4
Businesses contributed to Apex joint venture attributable to periods prior to contribution	—		—		6.9
Other	15.3		14.0		6.4
	$	458.3	$	334.5	$	191.1

Operations in Geographical Areas

Year Ended December 31

($ in millions)	2012		2011		2010
Sales:
United States	$	7,809.8	$	6,787.8	$	5,703.3
Germany	1,111.3		1,189.0		928.9
China	1,443.5		1,133.2		748.7
Japan	892.8		809.4		603.0
All other (each country individually less than 5% of total sales)	7,003.0		6,171.1		4,566.1
	$	18,260.4	$	16,090.5	$	12,550.0
Long-lived assets (Including assets held for sale):
United States	$	15,980.8	$	16,433.0	$	9,979.4
Germany	1,957.1		1,455.8		1,398.9
All other (each country individually less than 5% of total long-lived assets)	7,415.3		5,788.3		4,773.4
	$	25,353.2	$	23,677.1	$	16,151.7

Sales by Major Product Group

Year Ended December 31

($ in millions)	2012		2011		2010
Analytical and physical instrumentation	$	6,000.8	$	5,920.9	$	5,206.0
Medical & dental products	8,509.1		6,653.5		4,122.9
Motion and industrial automation controls	1,592.4		1,677.1		1,517.7
Mechanics and related hand tools	330.5		305.2		590.9
Product identification	1,410.3		1,162.1		818.4
All other	417.3		371.7		294.1
	$	18,260.4	$	16,090.5	$	12,550.0